Bell Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Bell Asset Management's EW Position: Q2 2025 in Review
Bell Asset Management sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 53,202 shares — an estimated $3.86M sold.
Bell Asset Management first reported a position in EW in Q1 2021 and held it in 17 quarters. The position peaked at $13.4M in Q4 2023. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.
- Bell Asset Management reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
- Bell Asset Management sold 53,202 Edwards Lifesciences shares in Q2 2025, an estimated $3.86M.
- Bell Asset Management first reported a position in Edwards Lifesciences in Q1 2021 and held it in 17 quarters.
- Bell Asset Management's Edwards Lifesciences position peaked at $13.4M in Q4 2023.
- 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.
Based on Bell Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.